NF2 and Vestibular schwannoma: The membrane protein merlin has been reported to exert a negative regulatory effect on mTORC1, and inhibiting the mTORC1 pathway in tumors lacking merlin could serve as a promising therapeutic target for vestibular schwannomas [85].